Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for CI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -503.00M
March 31, 2026 -637.00M
December 31, 2025 -420.00M
September 30, 2025 -4.387B
June 30, 2025 -797.00M
March 31, 2025 1.197B
December 31, 2024 -281.00M
September 30, 2024 -2.025B
June 30, 2024 -640.00M
March 31, 2024 -495.00M
December 31, 2023 -907.00M
September 30, 2023 -1.337B
June 30, 2023 -414.00M
March 31, 2023 -2.983B
December 31, 2022 -616.00M
September 30, 2022 4.901B
June 30, 2022 -272.00M
March 31, 2022 -915.00M
December 31, 2021 -302.00M
September 30, 2021 -710.00M
June 30, 2021 -2.307B
March 31, 2021 -717.00M
December 31, 2020 4.42B
September 30, 2020 -938.00M
June 30, 2020 -237.00M
Date Value
March 31, 2020 -269.00M
December 31, 2019 -271.00M
September 30, 2019 -304.00M
June 30, 2019 -634.00M
March 31, 2019 475.00M
December 31, 2018 -24.70B
September 30, 2018 125.00M
June 30, 2018 -99.00M
March 31, 2018 -1.70B
December 31, 2017 -603.00M
September 30, 2017 -368.00M
June 30, 2017 -615.00M
March 31, 2017 -117.00M
December 31, 2016 -985.00M
September 30, 2016 -1.088B
June 30, 2016 -168.00M
March 31, 2016 -333.00M
December 31, 2015 -1.302B
September 30, 2015 -201.00M
June 30, 2015 -47.00M
March 31, 2015 -49.00M
December 31, 2014 -350.00M
September 30, 2014 -573.00M
June 30, 2014 -326.00M
March 31, 2014 -506.00M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Centene Corp. -353.00M
CVS Health Corp. -1.884B
Humana, Inc. -273.00M
UnitedHealth Group, Inc. -1.798B
Elevance Health, Inc. 159.00M